ARA-290 (Cibinetide) | Research Grade | 10-Vial Pack
ARA-290 (Cibinetide) | Research Grade | 10-Vial Pack
ARA-290 (Cibinetide) Research Material
ARA-290 (Cibinetide) is an erythropoietin-derived peptide investigated in laboratory models involving innate repair receptor signaling and tissue-protection pathways. This listing is structured for qualified research organizations, analytical laboratories, and trained professionals requiring clearly identified material and consistent pack specifications.
Research applications
- Analytical method development and reference comparison
- Identity, purity, and stability studies
- Controlled in-vitro or preclinical research appropriate to the compound
Product specifications
- Category: Cytoprotective Research Peptide
- Format: Lyophilized research material
- Declared purity: 99.82%
- Common analytical methods: HPLC for purity assessment and LC-MS for identity confirmation
- Package configuration: 10 vials per selected specification
Available specifications
- 10mg × 10 vials
Storage and handling
Store lyophilized material at −20°C for long-term stability or at 2–8°C for short-term handling. Protect from light and moisture. Minimize repeated temperature cycling. Handle using appropriate laboratory procedures. Actual stability can vary by formulation and handling conditions.
Quality documentation
Lot-specific batch reference is assigned to each variant. Supporting analytical documentation, including a COA link, will be added before the product is activated for sale.
Important notice
For research use only. Not for human or veterinary use, ingestion, injection, diagnosis, treatment, cure, or prevention of disease. The purchaser is responsible for verifying legal status, institutional approvals, and suitability for the intended research application.